Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation

Simonetta Spinelli, Sandra Chiodi, S. Costantini, Maria Teresa Van Lint, Anna Maria Raiola, Gianbattista Ravera, Andrea Bacigalupo

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background and Objectives. Graft-versus-host disease (GVHD) is a complex syndrome observed after bone marrow transplantation (BMT) affecting several organs including the lower genital female tract. We tried to evaluate the incidence of genital tract involvement and whether there are specific risk factors. Design and Methods. A retrospective study was conducted in order to describe genital manifestations of GVHD and evaluate its incidence, severity and remission among 213 females who underwent BMT. The risk factors studied were previous pregnancies, vaginal cultures just before BMT and hormonal replacement therapy (HRT). Results. Genital lesions considered as expression of GVHD were found in 53 patients (24.9%). They appeared in the first 100 days after BMT in 12 women and beyond in 41 cases. Seventy-three percent of patients with such lesions showed some evidence of chronic GVHD elsewhere. The proposed grading, the first attempt of its kind, showed that genital chronic GVHD was minimal in 66%, moderate in 22% and severe in 12% of patients. Vaginal fibrosis, sometimes with complete obstruction, was seen in this last form. This occurred in 86.8% of patients after 2-157 months (median 22) while persistent GVHD was observed in 7 of them. In our sample no significant association was found between genital GVHD and previous pregnancies or vaginal infections at BMT, while HRT seems poorly associated with gynecological manifestations of GVHD (p=0.049). Interpretation and Conclusions. Genital GVHD is not unusual after BMT. It can seriously affect female sexuality and the overall quality of life. We suggest stressing the importance of early detection of genital involvement in order to prevent the most serious lesions. Further studies are needed to identify the triggering factors associated with the development of genital GVHD.

Original languageEnglish
Pages (from-to)1163-1168
Number of pages6
JournalHaematologica
Volume88
Issue number10
Publication statusPublished - Oct 2003

Fingerprint

Homologous Transplantation
Graft vs Host Disease
Bone Marrow Transplantation
Pregnancy
Incidence
Sexuality
Fibrosis
Retrospective Studies
Quality of Life

Keywords

  • Allogeneic transplantation
  • Graft-versus-host disease
  • Gynecological manifestations

ASJC Scopus subject areas

  • Hematology

Cite this

Spinelli, S., Chiodi, S., Costantini, S., Van Lint, M. T., Raiola, A. M., Ravera, G., & Bacigalupo, A. (2003). Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica, 88(10), 1163-1168.

Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. / Spinelli, Simonetta; Chiodi, Sandra; Costantini, S.; Van Lint, Maria Teresa; Raiola, Anna Maria; Ravera, Gianbattista; Bacigalupo, Andrea.

In: Haematologica, Vol. 88, No. 10, 10.2003, p. 1163-1168.

Research output: Contribution to journalArticle

Spinelli, S, Chiodi, S, Costantini, S, Van Lint, MT, Raiola, AM, Ravera, G & Bacigalupo, A 2003, 'Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation', Haematologica, vol. 88, no. 10, pp. 1163-1168.
Spinelli, Simonetta ; Chiodi, Sandra ; Costantini, S. ; Van Lint, Maria Teresa ; Raiola, Anna Maria ; Ravera, Gianbattista ; Bacigalupo, Andrea. / Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. In: Haematologica. 2003 ; Vol. 88, No. 10. pp. 1163-1168.
@article{93698cb4b5624462a3b31c993192f859,
title = "Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation",
abstract = "Background and Objectives. Graft-versus-host disease (GVHD) is a complex syndrome observed after bone marrow transplantation (BMT) affecting several organs including the lower genital female tract. We tried to evaluate the incidence of genital tract involvement and whether there are specific risk factors. Design and Methods. A retrospective study was conducted in order to describe genital manifestations of GVHD and evaluate its incidence, severity and remission among 213 females who underwent BMT. The risk factors studied were previous pregnancies, vaginal cultures just before BMT and hormonal replacement therapy (HRT). Results. Genital lesions considered as expression of GVHD were found in 53 patients (24.9{\%}). They appeared in the first 100 days after BMT in 12 women and beyond in 41 cases. Seventy-three percent of patients with such lesions showed some evidence of chronic GVHD elsewhere. The proposed grading, the first attempt of its kind, showed that genital chronic GVHD was minimal in 66{\%}, moderate in 22{\%} and severe in 12{\%} of patients. Vaginal fibrosis, sometimes with complete obstruction, was seen in this last form. This occurred in 86.8{\%} of patients after 2-157 months (median 22) while persistent GVHD was observed in 7 of them. In our sample no significant association was found between genital GVHD and previous pregnancies or vaginal infections at BMT, while HRT seems poorly associated with gynecological manifestations of GVHD (p=0.049). Interpretation and Conclusions. Genital GVHD is not unusual after BMT. It can seriously affect female sexuality and the overall quality of life. We suggest stressing the importance of early detection of genital involvement in order to prevent the most serious lesions. Further studies are needed to identify the triggering factors associated with the development of genital GVHD.",
keywords = "Allogeneic transplantation, Graft-versus-host disease, Gynecological manifestations",
author = "Simonetta Spinelli and Sandra Chiodi and S. Costantini and {Van Lint}, {Maria Teresa} and Raiola, {Anna Maria} and Gianbattista Ravera and Andrea Bacigalupo",
year = "2003",
month = "10",
language = "English",
volume = "88",
pages = "1163--1168",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "10",

}

TY - JOUR

T1 - Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation

AU - Spinelli, Simonetta

AU - Chiodi, Sandra

AU - Costantini, S.

AU - Van Lint, Maria Teresa

AU - Raiola, Anna Maria

AU - Ravera, Gianbattista

AU - Bacigalupo, Andrea

PY - 2003/10

Y1 - 2003/10

N2 - Background and Objectives. Graft-versus-host disease (GVHD) is a complex syndrome observed after bone marrow transplantation (BMT) affecting several organs including the lower genital female tract. We tried to evaluate the incidence of genital tract involvement and whether there are specific risk factors. Design and Methods. A retrospective study was conducted in order to describe genital manifestations of GVHD and evaluate its incidence, severity and remission among 213 females who underwent BMT. The risk factors studied were previous pregnancies, vaginal cultures just before BMT and hormonal replacement therapy (HRT). Results. Genital lesions considered as expression of GVHD were found in 53 patients (24.9%). They appeared in the first 100 days after BMT in 12 women and beyond in 41 cases. Seventy-three percent of patients with such lesions showed some evidence of chronic GVHD elsewhere. The proposed grading, the first attempt of its kind, showed that genital chronic GVHD was minimal in 66%, moderate in 22% and severe in 12% of patients. Vaginal fibrosis, sometimes with complete obstruction, was seen in this last form. This occurred in 86.8% of patients after 2-157 months (median 22) while persistent GVHD was observed in 7 of them. In our sample no significant association was found between genital GVHD and previous pregnancies or vaginal infections at BMT, while HRT seems poorly associated with gynecological manifestations of GVHD (p=0.049). Interpretation and Conclusions. Genital GVHD is not unusual after BMT. It can seriously affect female sexuality and the overall quality of life. We suggest stressing the importance of early detection of genital involvement in order to prevent the most serious lesions. Further studies are needed to identify the triggering factors associated with the development of genital GVHD.

AB - Background and Objectives. Graft-versus-host disease (GVHD) is a complex syndrome observed after bone marrow transplantation (BMT) affecting several organs including the lower genital female tract. We tried to evaluate the incidence of genital tract involvement and whether there are specific risk factors. Design and Methods. A retrospective study was conducted in order to describe genital manifestations of GVHD and evaluate its incidence, severity and remission among 213 females who underwent BMT. The risk factors studied were previous pregnancies, vaginal cultures just before BMT and hormonal replacement therapy (HRT). Results. Genital lesions considered as expression of GVHD were found in 53 patients (24.9%). They appeared in the first 100 days after BMT in 12 women and beyond in 41 cases. Seventy-three percent of patients with such lesions showed some evidence of chronic GVHD elsewhere. The proposed grading, the first attempt of its kind, showed that genital chronic GVHD was minimal in 66%, moderate in 22% and severe in 12% of patients. Vaginal fibrosis, sometimes with complete obstruction, was seen in this last form. This occurred in 86.8% of patients after 2-157 months (median 22) while persistent GVHD was observed in 7 of them. In our sample no significant association was found between genital GVHD and previous pregnancies or vaginal infections at BMT, while HRT seems poorly associated with gynecological manifestations of GVHD (p=0.049). Interpretation and Conclusions. Genital GVHD is not unusual after BMT. It can seriously affect female sexuality and the overall quality of life. We suggest stressing the importance of early detection of genital involvement in order to prevent the most serious lesions. Further studies are needed to identify the triggering factors associated with the development of genital GVHD.

KW - Allogeneic transplantation

KW - Graft-versus-host disease

KW - Gynecological manifestations

UR - http://www.scopus.com/inward/record.url?scp=0242267560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242267560&partnerID=8YFLogxK

M3 - Article

C2 - 14555313

AN - SCOPUS:0242267560

VL - 88

SP - 1163

EP - 1168

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -